Melatonine Orifarm

Melatonin, the active ingredient in Melatonine Orifarm, is a melatonin receptor agonist presented as an oral formulation for oral use. It is employed to help regulate the sleep‑wake cycle and to support the onset of sleep in adults with insomnia or related circadian rhythm disturbances.

GNH USA supplies Melatonine Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for importers. Products are shipped in compliance with Good Distribution Practice and can be tracked throughout the supply chain.

Melatonine Orifarm is a melatonin receptor agonist used to treat sleep‑related disorders by influencing circadian rhythm regulation.

- Insomnia: improves sleep onset and reduces nighttime awakenings. - Sleep‑wake rhythm disorder: helps synchronize the internal clock with external light‑dark cycles. - Delayed sleep phase disorder: advances sleep timing to achieve a more conventional bedtime.

Melatonine Orifarm may cause a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects: - Headache: mild to moderate discomfort. - Dizziness: transient sense of light‑headedness. - Daytime sleepiness: feeling unusually tired during waking hours. - Nausea: mild gastrointestinal upset. - Vivid dreams: unusually intense or memorable dreams.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe mood changes: depression or suicidal thoughts. - Hormonal effects: menstrual irregularities or decreased libido.

When considering Melatonine Orifarm, several precautionary measures should be observed to ensure safe use.

- Medical history review: assess liver function and existing sleep disorders. - Concomitant CNS depressants: avoid combining with benzodiazepines or alcohol. - Hepatic impairment: use with caution and monitor response. - Pediatric use: not recommended unless specifically prescribed. - Mood monitoring: watch for signs of depression or anxiety. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Melatonin can interact with other medicines, altering its effectiveness or increasing the risk of adverse events.

Major Interactions (Avoid): - Central nervous system depressants: may enhance sedative effects. - Anticoagulants: potential increase in bleeding risk.

Moderate Interactions (Monitor Closely): - CYP1A2 inhibitors (e.g., fluvoxamine): may raise melatonin levels. - CYP2C19 inhibitors (e.g., omeprazole): may increase exposure. - Antihypertensives: possible additive blood‑pressure lowering. - Oral contraceptives: may reduce contraceptive efficacy. - NSAIDs: may slightly increase bleeding tendency.